Emflaza approved by FDA for Duchenne muscular dystrophy – Clinical Advisor

Posted: Published on February 20th, 2017

This post was added by Dr Simmons


Clinical Advisor
Emflaza approved by FDA for Duchenne muscular dystrophy
Clinical Advisor
Emflaza was approved by the FDA to treat Duchenne muscular dystrophy in patients 5 years and older. (HealthDay News) Emflaza (deflazacort) has been approved by the US Food and Drug Administration to treat Duchenne muscular dystrophy (DMD) in ...

Continued here:
Emflaza approved by FDA for Duchenne muscular dystrophy - Clinical Advisor

Related Posts
This entry was posted in Muscular Dystrophy Treatment. Bookmark the permalink.

Comments are closed.